Correlation Between Zhejiang Expressway and SCANDMEDICAL SOLDK-040

Can any of the company-specific risk be diversified away by investing in both Zhejiang Expressway and SCANDMEDICAL SOLDK-040 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Zhejiang Expressway and SCANDMEDICAL SOLDK-040 into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Zhejiang Expressway Co and SCANDMEDICAL SOLDK 040, you can compare the effects of market volatilities on Zhejiang Expressway and SCANDMEDICAL SOLDK-040 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Zhejiang Expressway with a short position of SCANDMEDICAL SOLDK-040. Check out your portfolio center. Please also check ongoing floating volatility patterns of Zhejiang Expressway and SCANDMEDICAL SOLDK-040.

Diversification Opportunities for Zhejiang Expressway and SCANDMEDICAL SOLDK-040

-0.64

Correlation Coefficient

Zhejiang Expressway  SCANDMEDICAL SOLDK-040

Excellent diversification

The 3 months correlation between Zhejiang and SCANDMEDICAL is -0.64. Overlapping area represents the amount of risk that can be diversified away by holding Zhejiang Expressway Co and SCANDMEDICAL SOLDK 040 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SCANDMEDICAL SOLDK 040 and Zhejiang Expressway is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Zhejiang Expressway Co are associated (or correlated) with SCANDMEDICAL SOLDK-040. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SCANDMEDICAL SOLDK 040 has no effect on the direction of Zhejiang Expressway i.e., Zhejiang Expressway and SCANDMEDICAL SOLDK-040 go up and down completely randomly.

Pair Corralation between Zhejiang Expressway and SCANDMEDICAL SOLDK-040

Assuming the 90 days horizon Zhejiang Expressway Co is expected to generate 0.75 times more return on investment than SCANDMEDICAL SOLDK-040. However, Zhejiang Expressway Co is 1.34 times less risky than SCANDMEDICAL SOLDK-040. It trades about 0.07 of its potential returns per unit of risk. SCANDMEDICAL SOLDK 040 is currently generating about 0.01 per unit of risk. If you would invest  66.00  in Zhejiang Expressway Co on October 23, 2024 and sell it today you would earn a total of  1.00  from holding Zhejiang Expressway Co or generate 1.52% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Zhejiang Expressway Co  vs.  SCANDMEDICAL SOLDK 040

Zhejiang Expressway

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Zhejiang Expressway Co are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite nearly uncertain basic indicators, Zhejiang Expressway may actually be approaching a critical reversion point that can send shares even higher in February 2025.

SCANDMEDICAL SOLDK 040

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days SCANDMEDICAL SOLDK 040 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest fragile performance, the Stock's basic indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.

Pair Trading with Zhejiang Expressway and SCANDMEDICAL SOLDK-040

The main advantage of trading using opposite Zhejiang Expressway and SCANDMEDICAL SOLDK-040 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Zhejiang Expressway position performs unexpectedly, SCANDMEDICAL SOLDK-040 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SCANDMEDICAL SOLDK-040 will offset losses from the drop in SCANDMEDICAL SOLDK-040's long position.

The idea behind Zhejiang Expressway Co and SCANDMEDICAL SOLDK 040 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.